Yüksel Ürün

45PUBLICATIONS

140CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Basic pharmacologyPredictive and prognostic markersRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (45)

Sort by Publication Date:

|Jul 15, 2026

Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

|May 03, 2026

Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists.

|Apr 23, 2026

Less Can Be Enough: Optimizing Abiraterone Acetate Dosing With Food to Improve Access and Maintain Efficacy in Metastatic Castration-Resistant Prostate Cancer.

|Mar 26, 2026

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Mar 19, 2026

Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Mustafa Gürbüz, Deniz Tural, Timuçin Çil

|Mar 18, 2026

Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer.

Hatice Bölek, Yüksel Ürün

Pageof 8

Frequent Collaborators

13 joint publications

Emre Yekedüz

Hatime Arzu Yaşar

Güngör Utkan

Hatice Bolek

Elif Berna Köksoy

Beliz Bahar Karaoğlan

Nuri Karadurmuş

İrfan Çiçin

Mustafa Özgüroğlu

Merih Yalçıner

Frequent Collaborators

13 joint publications

Emre Yekedüz

7 joint publications

Hatime Arzu Yaşar

7 joint publications

Güngör Utkan

6 joint publications

Hatice Bolek